D. Aydemir Et Al. , "COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients," NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS , vol.40, no.5, pp.505-517, 2021
Aydemir, D. Et Al. 2021. COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS , vol.40, no.5 , 505-517.
Aydemir, D., Dağlıoğlu, G., Ulu, A., Kurtaran, B., Bozdogan, S., İnal, T. C., ... Ulusu, N. N.(2021). COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS , vol.40, no.5, 505-517.
Aydemir, Duygu Et Al. "COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients," NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS , vol.40, no.5, 505-517, 2021
Aydemir, Duygu Et Al. "COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients." NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS , vol.40, no.5, pp.505-517, 2021
Aydemir, D. Et Al. (2021) . "COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients." NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS , vol.40, no.5, pp.505-517.
@article{article, author={Duygu Aydemir Et Al. }, title={COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients}, journal={NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS}, year=2021, pages={505-517} }